What If Clinical Research Had Its Own Hippocratic Oath?

If we are responsible for life-changing interventions, why are researchers not subject to a codified ethical standard?

The Question No One Wants to Answer

Imagine a world where every clinical researcher, drug developer, and clinical trial sponsor takes a solemn oath before beginning their career, a commitment comparable to the Hippocratic Oath in medicine. A commitment not only to advance science, but also to uphold standards of ethics and integrity in every decision.

It sounds noble, doesn’t it? So why isn’t it already a reality?

In reality, despite the considerable stakes involved drug development, clinical trials, and the direct impact on patients’ lives there is no universal ethical oath binding researchers to a global standard. We have regulations. We have guidelines. But no oath.

Why? It’s complicated.

When Ethics Becomes a Guiding Principle… and Not an Obligation

In the medical field, the Hippocratic Oath acts as a moral compass clear, concise, and universally recognized. Yet, in clinical research, the ethical landscape is fragmented.

1. A set of guidelines:

• Good Clinical Practices (GCP) establish global standards, but remain guidelines.
• Institutional review boards (IRBs) oversee trials, but oversight varies considerably.
• Ethics committees apply local regulations, without overall consistency.

2. Industry pressures:

• Financial motivations can take precedence over the well-being of patients.
• Accelerated approval processes sometimes bypass thorough ethical review.
• Conflicts of interest arise when researchers have financial interest in the results.

3. Absence of individual responsibility:

• When is a researcher held personally responsible for unethical conduct?
• Most sanctions target companies, not individuals.

So, what is the patient’s place in all of this? Who protects the human aspect in clinical trials?

The Silence of Ethics

Ethics exists in the sector, but often as a procedure rather than a personal value. A universal oath could change that.

Imagine this:

“I pledge to place patient safety above all else. I will not manipulate any data, conceal any adverse events, or prioritize profit over human well-being. My work will be guided by truth, transparency, and respect for human dignity.”

Now imagine each researcher standing before their peers and patients, publicly making this commitment.

Would that change anything? Would it strengthen trust? Or would it be perceived as a public relations maneuver rather than a moral commitment?

A Commitment or a Publicity Stunt?

Critics argue that an oath will not change corporate behavior. At best, it is symbolic; at worst, ineffective.

However, symbols matter. The Hippocratic Oath does not prevent all professional misconduct, but it reminds us that medicine is a moral practice, and not just a technical one.

Similarly, a clinical research oath will not end unethical practices overnight. But it would allow:

• To change the culture: to remind people that research is a privilege, not just a job.
• To strengthen accountability: personalize responsibilities rather than hiding them between departments.
• Building trust: publicly acknowledging responsibility improves credibility with patients and stakeholders.

What Would the Oath Look Like?

Here is a project to consider:

The clinical research oath:

1. I will put the health and well-being of the participants before any professional, financial or organizational interest.
2. I will not falsify data or conceal results, regardless of external pressures.
3. I will respect patient autonomy, ensuring their informed consent and transparent communication.
4. I will guarantee the integrity of all phases of the research, from trial design to data publication.
5. I will remain vigilant regarding conflicts of interest and will systematically disclose them.

Would Researchers Adopt It?

Would sponsors support it? Or would the industry resist, fearing that such a commitment would attract too much attention?

Why Now?

The world is watching us. Recent controversies from data manipulation to security issues have highlighted ethical lapses. Public trust is eroding. An oath could symbolize a renewed commitment to integrity.

But above all, it would remind researchers that beyond protocols, data and testing phases, there are real human lives.

A Challenge for the Industry

• To the leaders: dare to implement this. Lead by example. Be the first to make a public commitment.
• To the researchers: would you take this oath? Would you proudly declare your commitment to ethical standards in clinical research?
• To patients’ demands: Your lives should not be reduced to data or spreadsheets. You deserve for every researcher to be held to more than just regulatory obligations.

My Final Thoughts

Science and humanity should never be opposed. Innovation must never come at the expense of ethics.

The real question may not be whether we need an oath, but why we have gone so long without one.

Abel Vissoukpo

Abel Vissoukpo is a Clinical Research Associate (CRA) and Public Health Researcher passionate about transforming clinical research and public health initiatives into GCP-compliant, patient-centered, and data-driven outcomes. With solid experience in Clinical Research Operations, Healthcare Project Coordination, and Clinical Monitoring, he is committed to delivering high-quality research, upholding ethical standards, and driving measurable impact.

Over the years, Abel has coordinated and contributed to health and clinical research projects benefiting more than 500 patients. He has also implemented digital and AI-driven solutions that improved project efficiency by 30%, strengthening operational performance and overall research outcomes.